hims and hers glp 1 & @Hers is expanding its GLP-1 ambitions. The telehealth giant has acquired European platform @Eucalyptus.Health as it pushes further into weight care, just as new FDA developments could reshape the future Novo Nordisk Forms GLP-1 Partnership

Additionally, lawsuits alleging blood clots and pulmonary embolism have been filed outside of the MDLs

this ligand is then converted to the Y2-R agonist PYY 3-36 via enzymatic cleavage by DPPIV 69,70

The FDAs Pharmacy Compounding Advisory Committee (PCAC) will review seven peptides to potentially allow compounders to produce them

A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma

Reuters article Hair loss with GLP-1 drugs is rare, but real, studies find (Open access) See more from MedicalBrief archives: Doctors reminded to flag side effects of GLP-1 agonists US study finds serious side effects from weight-loss drugs FDA approves first Farxiga generics for type 2 diabetes FDA, Merck accused of covering up hair-loss pills suicide link